Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine, alone or in combination with a low-dose diuretic, in elderly patients with isolated systolic hypertension (Val-syst Study)

Blood Pressure Monitoring

Volumn 9, Issue 2, 2004, Pages 91-97

  Palatini, Paolo ^a   Mugellini, Amedeo ^b   Spagnuolo, Vitaliano ^c   Santonastaso, Massimo ^d   Ambrosio, Giovanni Battista ^d   Caiazza, Alberto ^e   Malacco, Ettore ^f  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Osp Civ Annunziata   (Italy)

^d Ospedale Civile   (Italy)

^e Centro Ipertensione   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; VALSARTAN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREATMENT OUTCOME;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; TETRAZOLES; VALINE;

EID: 2342477170     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200404000-00006     Document Type: Article

References (37)

1. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, at al., for the SAMPLE Study Group. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95:1464-1470.
2. Mancia G, Omboni S, Ravogli A, Parati Q, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of anti-hypertensive treatment: additional information from a large data base. Blood Press 1995; 4:148-156.
3. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional versus ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546.
4. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M, et al. Clinical relevance of night-time blood pressure and day-time blood pressure variability. Arch Intern Med 1992; 152:1855-1860.
5. Sega R, Cesana G, Milesi C, Grassi G, Zanchetti A, Mancia G. Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. Hypertension 1997; 30:1-6.
6. Kario K, Mitsuhashi T, Shimada K. Neurohumoral characteristics of older hypertensive patients with abnormal nocturnal blood pressure dipping. Am J Hypertens 2002; 15:531-537.
7. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38:852-857.
8. Puisieux F, Bulckaen H, Fauchais AL, Drumez S, Salomez-Granier F, Dewailly P. Ambulatory blood pressure monitoring and post-prandial hypotension in elderly persons with falls or syncopes. J Gerontol A Biol Sci Med Sci 2000; 55:535-540.
9. Gerritsen J, TenVoorde BJ, Dekker JM, Kingma R, Kostense PJ, Bouter LM, et al. Measures of cardiovascular autonomic nervous function: agreement, reproducibility, and reference values in middle-aged and elderly subjects. Diabetologia 2003; 46:330-338.
10. Malacco E, Vari N, Capuano V, Spagnuolo V, Borgnino C, Palatini P. A randomized, double blind, controlled, parallel-group comparison of valsartan and amlodipine for the treatment of isolated systolic hypertension in the elderly: the Val-Syst Study. Clin Ther 2003; 25:2765-2780.
11. Palatini P, Penzo M, Canali C, Pessina AC. Validation of the accuracy of the A&D™ 2420 model 7 for ambulatory blood pressure monitoring and effect of microphone replacement on its performance. J Amb Monitor 1991; 4:281-288.
12. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the Spacelabs 90207 determined by the British Hypertension Society protocol. J Hypertens 1991; 9:573-575.
13. Winnicki M, Canali C, Mormino P, Palatini P. Ambulatory blood pressure monitoring editing criteria: is standardization needed? Am J Hypertens 1997; 10:419-427.
14. Omboni S, Parati G, Zanchetti A, Mancia G. Calculation of trough/peak ratio of anti-hypertensive treatment from ambulatory blood pressure: methodological aspects. J Hypertens 1995; 13:1105-1112.
15. Palatini P. Importance of various methods of blood pressure measurement in clinical trials. Curr Hypertens Rep 2000; 2:362-369.
16. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998; 16:1685-1691.
17. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-h blood pressure mean and variability to severity of target organ damage. J Hypertens 1987; 5:93-98.
18. Palatini P, Malacco E, Di Somma S, Carretta R, Dorigatti F, Bertocchi F, et al. Trough/peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine. Eur J Clin Pharmacol 2002; 57:765-770.
19. Neutel JM, Smith DHG, Ram CVS, Kaplan NM, Papademetriou V, Fagan TC, et al. Application of ambulatory blood pressure monitoring in differentiating between anti-hypertensive agents. JAMA 1993; 94:181-187.
20. O'Brien E, O'Malley K, Cox J, Stanton A. Ambulatory blood pressure monitoring in the evaluation of drug efficacy. Am Heart J 1991; 121:999-1006.
21. Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reduction in blood pressure. Am J Hypertens 1997; 10:261-268.
22. Imai Y, Abe K, Nishiyama A, Sekino M, Yoshinaga K. Evaluation of the anti-hypertensive effect of bamidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24-h, daytime, and night-time. Bamidipine Study Group. Am J Hypertens 1997; 10:1416-1419
23. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27:130-135.
24. Shuaib A. Alteration of blood pressure regulation and cerebrovascular disorders in the elderly. Cerebrovasc Brain Metab Rev 1992; 4:329-345.
25. Mizunuma Y, Suzuki-Kusaba M, Hisa H, Yoshida M, Satoh S. Participation of angiotensin II in pressor response and norepinephrine release to spinal nerve stimulation in pithed rats. Biol Pharm Bull 2000; 23:1455-1457.
26. Preobrazhensky DV, Stepanova OA, Kiktev VG, Shatunova IM. Eprosartan - a novel angiotensin II receptor antagonist with sympatho-inhibitory activity. Clinical efficacy and safety in arterial hypertension. Kardiologiya 2000; 40:93-99.
27. Kailasam MT, Parmer RJ, Cervenka JH, Wu RA, Ziegler MG, Kennedy BP, et al. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 1995; 26:143-149.
28. Ueda S, Meredith PA, Howie CA, Elliott HL. Long-acting calcium antagonists: amlodipine versus nifedipine gastrointestinal therapeutic system (GITS). J Hypertens 1993; 11(Suppl 5):S332-S333.
29. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162:2313-2321.
30. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
31. Sica DA. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs 2002; 62:443-462.
32. SHEP Cooperative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Ass 1991; 265:3255-3264.
33. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350:757-74.
34. Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo for older patients with isolated systolic hypertension. J Hypertens 1998; 16:1823-1829.
35. Staessen JA, Wang JG. Benefit of anti-hypertensive drug treatment in older patients with isolated systolic hypertension. Eur Heart J 1999; 1(Suppl P):P3-P8.
36. Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanka J, Schersten B, et al. Randomised trial of old and new anti-hypertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354:1751-1756.
37. Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356:366-372.